Mezue Wilfred C, Ohaegbulam Samuel C, Ndubuisi Chikandu A, Chikani Mark C, Achebe David S
Department of Neurosurgery, University of Nigeria Teaching Hospital, Enugu, Nigeria.
Surg Neurol Int. 2012;3:110. doi: 10.4103/2152-7806.101788. Epub 2012 Sep 28.
Meningiomas may range on presentation from incidentally identified small lesions to large symptomatic tumors in eloquent areas of the brain. Management options correspondingly vary and include careful observation, surgical excision, and palliative application of very limited therapeutic maneuvers in select cases. This paper discusses the options and difficulties in the management of meningiomas in a developing country.
This study is a retrospective analysis of prospectively recorded data of patients managed for intracranial meningioma between January 2006 and September 2011 at Memfys Hospital for Neurosurgery, Enugu. Radiographic diagnosis of meningioma was based on computed tomography (CT) and or magnetic resonance imaging (MRI) criteria in all cases, but only patients who had surgery and a histological diagnosis were analyzed.
Seventy-four patients were radiographically diagnosed with intracranial meningioma over the period under review. Fifty-five patients were operated upon and 52 (70.3%) with histological diagnosis of meningioma were further analyzed. Histological diagnosis was complete in 42 (56.8%) patients and in 10 (13.5%) patients the subtype of meningioma was not determined. The male to female ratio was 1:1.08. The peak age range for females was in the 6th decade and for males in the 5th decade. The locations were olfactory groove (26.9%), convexity (21.2%), parasagittal/falx (19.2%), sphenoid ridge (15.4%), tuberculum sellae (7.7%), tentorial (3.8%), and posterior fossa (5.8%). The most common clinical presentation was headaches in 67.3% followed by seizures (40.4%) and visual impairment (38.5%). Histology was benign (World Health Organization [WHO] grade 1) in 39 patients. One patient harbored an atypical and two had anaplastic tumors. Gross total resection of the tumor was achieved in 41 patients. Surgical mortality was 3.9%.
Effective management of meningioma depends largely on adequate and complete surgical resection and results in good outcomes. Adequate preoperative assessment, including visual assessment, and hormonal assessment in olfactory groove and sphenoid region meningiomas, is necessary.
脑膜瘤的临床表现多样,从偶然发现的小病灶到大脑功能区的大型有症状肿瘤不等。相应地,治疗选择也各不相同,包括密切观察、手术切除,以及在特定病例中采用非常有限的姑息性治疗手段。本文讨论了在一个发展中国家管理脑膜瘤的选择和困难。
本研究是对2006年1月至2011年9月在埃努古Memfys神经外科医院接受颅内脑膜瘤治疗的患者的前瞻性记录数据进行的回顾性分析。所有病例中脑膜瘤的影像学诊断均基于计算机断层扫描(CT)和/或磁共振成像(MRI)标准,但仅分析了接受手术并获得组织学诊断的患者。
在审查期间,有74例患者经影像学诊断为颅内脑膜瘤。55例患者接受了手术,其中52例(70.3%)经组织学诊断为脑膜瘤的患者被进一步分析。42例(56.8%)患者获得了完整的组织学诊断,10例(13.5%)患者未确定脑膜瘤的亚型。男女比例为1:1.08。女性的发病高峰年龄在60多岁,男性在50多岁。肿瘤位置分别为嗅沟(26.9%)、凸面(21.2%)、矢状窦旁/大脑镰(19.2%)、蝶骨嵴(15.4%)、鞍结节(7.7%)、小脑幕(3.8%)和后颅窝(5.8%)。最常见的临床表现是头痛(67.3%),其次是癫痫发作(40.4%)和视力障碍(38.5%)。39例患者的组织学检查为良性(世界卫生组织[WHO]1级)。1例患者患有非典型肿瘤,2例患有间变性肿瘤。41例患者实现了肿瘤的全切除。手术死亡率为3.9%。
脑膜瘤的有效管理很大程度上取决于充分和完整的手术切除,并能取得良好的效果。术前进行充分评估是必要的,包括视力评估,以及对嗅沟和蝶骨区域脑膜瘤进行激素评估。